The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured

BACKGROUND: VSL#3 has been extensively investigated and is currently recommended for the prevention and treatment of chronic pouchitis and ulcerative colitis. Nonetheless, in vitro and in vivo stud-ies have recently shown variability in the VSL#3 efficacy often attributed to the manufacturing proces...

Descripción completa

Detalles Bibliográficos
Autores principales: Palumbo, Paola, Lombardi, Francesca, Cifone, Maria Grazia, Cinque, Benedetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425067/
https://www.ncbi.nlm.nih.gov/pubmed/30360752
http://dx.doi.org/10.2174/1871530318666181022164505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425067/
https://www.ncbi.nlm.nih.gov/pubmed/30360752
http://dx.doi.org/10.2174/1871530318666181022164505

Ejemplares similares